DOI: https://doi.org/10.26641/2307-0404.2018.3(part1).142343

Clinical and pathogenic aspects of vibrational disease and comorbid pathologies.

V. A. Kapustnyk, O. L. Arkhipkina, L. A. Poliakova, N. K. Sukhonos

Abstract


Despite the tendency to decrease in the level of vibrational disease morbidity, this pathology is third in the structure of occupational diseases in Ukraine. According to research design, we have examined 178 vibrational disease patients of I and II degree due to local vibration. They have been divided into 3 groups: first — 66 patients with vibrational disease and chronic obstructive pulmonary disease; second — 60 patients with vibrational disease and arterial hypertension of II degree, and group of comparison – 52 patients with isolated course of vibrational disease. We have used clinical and physiological, ELISA methods to estimate cytokines levels in these patients. We have found that clinical signs of vibrational disease depend on vibrational disease progressing and comorbid pathologies. Overlay of chronic obstructive pulmonary disease to vibra­tional disease significantly worsens disease course, manifested by augmenting of clinical symptoms, neurovascular and trophic violations. Comorbid course of vibrational disease and arterial hypertension leads to respective worsening of cardio-vascular pathology. One of the mechanisms of development and progressing of vibrational disease is imbalance of cytokine chain of immunity — increase of the amount of inflammatory cytokine TNF-α and decrease of anti-inflammatory — IL-10. Overlay of chronic obstructive pulmonary disease enhances this trend. In patients with comorbid course of vibrational disease and arterial hypertension we have observed development of secondary dysregulatory state of immunocompetent system. This is proved by increased levels of inflammatory cytokines (TNF-α by 62.5 % and IL-8 by 46.5 %), and decreased activity of melatonin by 35.0 % in comparison with group of patients with isolated vibrational disease.

Keywords


vibrational disease; arterial hypertension; chronic obstructive pulmonary disease; hormones; cytokines

References


Zhuravlova LV, Olijnyk MO. [The role of pro­inflammatory cytokines in the development of osteo­arthritis and diabetes mellitus type]. Ukrayinsky rev­matologichny Journal. 2015;60(2):31-35. Ukrainian.

Nikitin YeV , Chaban TV, Serveczky SK. [Mo­dern ideas about the system of cytokines]. Infektsiini khvoroby. 2007;2:64-69. Ukrainian.

Orzheshkovskyi VV. [Polyneuropathy (patho­ge­netic mechanisms, clinical-paraclinical features, diag­nostic approaches]. [dissertation]. Kyiv, UA, Shupyk na­tional medical academy of postgraduate education. 2018;32. Ukrainian.

Hryniuk SV, Bazovkin PS, Matviichuk TD, Hry­niuk VO. [Assessment of health damage from vibration sickness from general vibration by the integral valuation indicator DALY]. Visnyk problem biolohii i medytsyny. 2016;2(3):284-287. Ukrainian.

Arustamian OM, Tkachyshyn VS, Kondratiuk VYe, Korzh AV, Aleksiichuk OYu. [Modern problems of occupational pathology in Ukraine]. Environment and Health. 2017;4:62-67. Ukrainian.

Bovenzi M., D’Agostin F., Rui F. Salivary endo­thelin and vascular disorders in vibration‒exposed wor­kersю Scandinavian Journal of Work, Environment & Health. 2008;34(2):133-141.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Ma­nagement and Prevention of COPD; 2016. Available from: http://goldcopd.org.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD; 2017. Available from: http://goldcopd.org.


GOST Style Citations


  1. Журавльова Л.В. Роль прозапальних цитокінів у розвитку остеоартрозу та цукрового діабету іі типу / Л.В. Журавльова, М.О. Олійник. // Укр. ревматол. журнал. – 2015. – № 60. – С. 31-35.
  2. Нікітін Є. В. Сучасні уявлення про систему цитокінів / Є.В. Нікітін, Т.В. Чабан, С. К. Сервець­кий. // Інфекційні хвороби. – 2007. – № 2. – С. 64-69.
  3. Оржешковський В.В. Полінейропатії (пато­гене­тичні механізми, клініко-параклінічні особли­вості, діагностичні підходи: автореф. дис. на здобуття наук. ступеня д-ра. мед. наук: спец. 14.01.15 "Нервові хвороби" / Оржешковський В. В. – Київ, 2018. – 32 с.
  4. Оцінка шкоди здоров’ю від вібраційної хво­роби від загальних вібрацій за інтегральним оці­ночним показником DALY / С.В.Гринюк, П.С. Ба­зов­кін, Т.Д. Матвійчук, В.О. Гринюк. // Вісник проблем біології і медицини. – 2016. – № 2 (3). – С. 284-287.
  5. Сучасні проблеми професійної патології в Україні / Арустамян О.М., Ткачишин В.С., Кондра­тюк В.Є., Корж А.В. [та ін.] // Environment and Health. – 2017. – № 4. – С. 62-67.
  6. Bovenzi М. Salivary endothelin and vascular di­sorders in vibration‒exposed workers / Bovenzi М., D’Agostin,, F., & Rui, F. // Scandinav. J. Work, Environ­ment Health. – 2008. – Vol. 34. – P. 133-141.
  7. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Ma­nagement and Prevention of COPD, 2016. Available at: http://goldcopd.org
  8. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD, 2017. Available at: http://goldcopd.org